Xu JJ - Search Results

1

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.

Xu JJ, Diaz P, Astruc-Diaz F, Craig S, Munoz E, Naguib M. Xu JJ, et al. Anesth Analg. 2010 Jul;111(1):99-109. doi: 10.1213/ANE.0b013e3181e0cdaf. Epub 2010 Jun 3. Anesth Analg. 2010. PMID: 20522703 Free PMC article.

2

Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance.

Xu JJ, Walla BC, Diaz MF, Fuller GN, Gutstein HB. Xu JJ, et al. Anesth Analg. 2006 Sep;103(3):714-20. doi: 10.1213/01.ane.0000226100.46866.ea. Anesth Analg. 2006. PMID: 16931686

3

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

Diaz P, Xu J, Astruc-Diaz F, Pan HM, Brown DL, Naguib M. Diaz P, et al. J Med Chem. 2008 Aug 28;51(16):4932-47. doi: 10.1021/jm8002203. Epub 2008 Jul 31. J Med Chem. 2008. PMID: 18666769

4

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.

Naguib M, Diaz P, Xu JJ, Astruc-Diaz F, Craig S, Vivas-Mejia P, Brown DL. Naguib M, et al. Among authors: xu jj. Br J Pharmacol. 2008 Dec;155(7):1104-16. doi: 10.1038/bjp.2008.340. Epub 2008 Sep 1. Br J Pharmacol. 2008. PMID: 18846037 Free PMC article.

5

6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.

Diaz P, Phatak SS, Xu J, Astruc-Diaz F, Cavasotto CN, Naguib M. Diaz P, et al. J Med Chem. 2009 Jan 22;52(2):433-44. doi: 10.1021/jm801353p. J Med Chem. 2009. PMID: 19115816

6

2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.

Diaz P, Phatak SS, Xu J, Fronczek FR, Astruc-Diaz F, Thompson CM, Cavasotto CN, Naguib M. Diaz P, et al. ChemMedChem. 2009 Oct;4(10):1615-29. doi: 10.1002/cmdc.200900226. ChemMedChem. 2009. PMID: 19637157 Free PMC article.

7

Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.

Naguib M, Xu JJ, Diaz P, Brown DL, Cogdell D, Bie B, Hu J, Craig S, Hittelman WN. Naguib M, et al. Among authors: xu jj. Anesth Analg. 2012 May;114(5):1104-20. doi: 10.1213/ANE.0b013e31824b0191. Epub 2012 Mar 5. Anesth Analg. 2012. PMID: 22392969 Free PMC article.

8

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency.

Wu J, Bie B, Yang H, Xu JJ, Brown DL, Naguib M. Wu J, et al. Among authors: xu jj. Neurobiol Aging. 2013 Mar;34(3):791-804. doi: 10.1016/j.neurobiolaging.2012.06.011. Epub 2012 Jul 12. Neurobiol Aging. 2013. PMID: 22795792

9

In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.

Astruc-Diaz F, McDaniel SW, Xu JJ, Parola S, Brown DL, Naguib M, Diaz P. Astruc-Diaz F, et al. Among authors: xu jj. J Pharm Sci. 2013 Feb;102(2):352-64. doi: 10.1002/jps.23393. Epub 2012 Nov 28. J Pharm Sci. 2013. PMID: 23192786 Free PMC article.

10

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency.

Wu J, Bie B, Yang H, Xu JJ, Brown DL, Naguib M. Wu J, et al. Among authors: xu jj. Neurobiol Aging. 2013 Dec;34(12):2843-52. doi: 10.1016/j.neurobiolaging.2013.06.003. Epub 2013 Jul 12. Neurobiol Aging. 2013. PMID: 23855980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,565 results

Search Page

Filters